Evaluation of the pharmacological effect of Argeria Nervosa bojar. plant on respiratory tract infection: A systemic review.

Argyreia nervosa bojar, a traditional and aesthetic medicinal plant is native to the Indian subcontinent. It has a large variety of traditional uses and therapeutically proven activities such as analgesic & anti-inflammatory, anti-cancer, anti-convulsant, anti-diarrheal, anti-fungal, antimicrobial, anti-obesity, antipyretic, anti-stress, anti-ulcer, anti-viral, aphrodisiac, CNS effect, hepatoprotective, hypoglycaemic, immunomodulatory, nootropic, wound healing activity, skin disorders, gonorrhoea, diabetes and sexual disorders. We aimed to systematically analyse pharmacological importance of A. nervosa to treat respiratory tract infection. As respiratory tract infection is accompanied with fever, pain, and inflammation. We collected literature from various online databases on antimicrobial, antipyretics, analgesic and anti-inflammatory activity of A. nervosa. We analysed the data based on eligibility criteria of the study and noted that, A. nervosa has high potential to treat many diseases, but it is ignored by researchers to find its pharmacological effect on respiratory tract infection. Our review found only four appropriate literatures available on various databases. This plant parts were noted effective against microbial activity of Streptococcus pneumoniae and Mycobacterium tuberculosis, responsible for causing respiratory tract infections. Its extracts also exhibited significant antipyretic, analgesic and anti-inflammatory activity in mice, an experimental model. [ABSTRACT FROM AUTHOR]